Debt Zmiana Data
Acadia Pharmaceuticals USD 0 0 2022-06
Agios Pharmaceuticals USD 1.14M 84K 2022-09
Akebia Therapeutics USD 34.68M 7.93M 2023-12
Amgen USD 64.61B 4.15B 2023-12
AstraZeneca USD 28.58B 1.26B 2023-09
Bayer EUR 47.42B 907M 2023-09
BioMarin Pharmaceutical USD 1.09B 988K 2023-12
Bristol-Myers Squibb USD 39.77B 2.17B 2023-12
Cytokinetics USD 618.45M 9.43M 2023-12
Eisai JPY 133.23B 2.99B 2023-09
Eli Lilly USD 20.17B 1.35B 2023-09
Esperion Therapeutics USD 261.16M 427K 2023-09
Exelixis USD 0 0 2022-03
Genmab DKK 793M 10M 2023-09
Incyte USD 32.6M 678K 2023-12
Ionis Pharmaceuticals USD 1.27B 14.67M 2023-12
MacroGenics USD 0 0 2022-06
Merck USD 34.86B 2.05B 2023-09
Moderna USD 575M 150M 2023-12
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 169.9M 200K 2023-09
Novartis USD 210M 28.09B 2023-09
Pfizer USD 63.6B 1.74B 2023-09
Takeda JPY 4.68T 67.91B 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06
Xencor USD 20.97M 20.97M 2023-12



Exelixis DŁUG - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.